Flora Growth Corp. (FLGC)
- Previous Close
1.3700 - Open
1.3800 - Bid 1.3200 x 100
- Ask 1.4000 x 100
- Day's Range
1.3400 - 1.4699 - 52 Week Range
0.1710 - 5.4800 - Volume
221,935 - Avg. Volume
840,436 - Market Cap (intraday)
17.302M - Beta (5Y Monthly) 1.99
- PE Ratio (TTM)
-- - EPS (TTM)
-6.3400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.00
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
www.floragrowth.com97
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: FLGC
Performance Overview: FLGC
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FLGC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FLGC
Valuation Measures
Market Cap
17.30M
Enterprise Value
16.62M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.13
Price/Book (mrq)
2.70
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-74.98%
Return on Assets (ttm)
-12.96%
Return on Equity (ttm)
-148.59%
Revenue (ttm)
76.07M
Net Income Avi to Common (ttm)
-47.36M
Diluted EPS (ttm)
-6.3400
Balance Sheet and Cash Flow
Total Cash (mrq)
4.35M
Total Debt/Equity (mrq)
57.34%
Levered Free Cash Flow (ttm)
515.12k
Research Analysis: FLGC
Company Insights: FLGC
FLGC does not have Company Insights